7 research outputs found
Influence of FPR cut-offs on PPV and number of patients elegible for MVC treatment.
<p>Values were calculated using all available RNA (n = 87) and DNA (n = 60) samples; ESTA (n = 37); NGS (n = 45). * No NGS values for the NGS FPR cut-off of 7.5% were available.</p
Concordance between the genotypic, ESTA and NGS results.
<p>Values were calculated using 37 samples for ESTA comparison and 45 samples for NGS analysis. g2p: geno2pheno<sub>[coreceptor]</sub>.</p
Influence of FPR cut-offs and triple amplification on PPV and number of patients elegible for MVC.
<p>Depicted data correspond to the 27 RNA plus 28 DNA samples that could be amplified in triplicate.</p
Baseline characteristics.
<p>Panel A: Number of active drugs in the GSS. Panel B: Distribution of the FPR of the baseline viruses: 87 RNA and 60 DNA sequences with single population-based sequencing, and 20 RNA and 18 DNA samples analysed by NGS.</p
Prevalence of HIV-positive test by ethnicity and region.
<p>Prevalence of HIV-positive test by ethnicity and region.</p
Patient characteristics by European region.
1<p>North:Denmark, Sweden, Netherlands, UK, West Central: Austria, Belgium, Germany, East Central: Belarus, Bosnia, Croatia, Poland, Ukraine and South: Italy and Spain.</p>2<p>IQR:Interquartile range.</p>3<p>STI: Sexually transmitted infection, LYM: Malignant lymphoma, CAN: Cervical or anal cancer/dysplasia, HZV: Herpes zoster, HEP: Hepatitis B or C, MON: Ongoing mononucleosis-like illness, CYT: Unexplained leukocytopenia/thrombocytopenia lasting >4 weeks, SEB: Seborrheic dermatitis/exanthema (SEB).</p><p>Missing data: 10 (0.3%) gender, 120 (3.3%) ethnicity, 63 (1.8%) age, 120 (3.3%) sexual orientation, 291 (8.1%) previous HIV test.</p
Prevalence of HIV by indicator condition.
*<p>Unpublished prevalence data from participating study sites.</p>**<p>includes MSM, IDU prevalence.</p>***<p>UNAIDS adults aged 15–49 country HIV prevalence rate <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0052845#pone.0052845-UNAIDS2" target="_blank">[31]</a>.</p